Promius Pharma LLC, a subsidiary of Dr. Reddy’s Laboratories, unveiled its new visual identity and corporate brand: The Power of Humans Being.
Omnicom Health Group announced that it is creating DDB Health, a dedicated, integrated healthcare network combining several U.S. and European professional healthcare agencies.
Tesaro Inc.’s experimental ovarian cancer drug niraparib met the main goal of prolonging survival in patients – without the disease worsening – in a late-stage trial.
The U.S. FDA is requesting additional data to support the safety and effectiveness of certain active ingredients used in topical consumer antiseptic rubs, including hand sanitizers, that are sold over-the-counter.
Irish drugmaker Shire Plc said a study testing an experimental drug to treat attention-deficit disorder met the main goal, bringing the drug one step closer to approval in the United States.
Lipocine Inc. said its oral testosterone replacement product did not get the approval in the United States, sending the drugmaker’s shares down 52 percent in premarket trading.
Esperion Therapeutics is on track to initiate global pivotal Phase 3 studies and global cardiovascular outcomes trial in fourth-quarter 2016 for Bempedoic Acid.
Aligned with global regulatory authorities on a consistent definition of statin intolerance
The U.S. Food and Drug Administration’s high-profile cancer drug director, Dr. Richard Pazdur, has been named head of a newly created Oncology Center of Excellence that will coordinate the review of all the agency’s cancer therapeutics.
A U.S. Food and Drug Administration Advisory Committee voted 12-11 that substantial evidence exists to establish that Jardiance (empagliflozin) reduces cardiovascular (CV) death in adults with type 2 diabetes and established CV disease. Jardiance, which is marketed by Boehringer Ingelheim and Eli Lilly, is the only oral T2D medicine shown in a clinical trial to reduce the risk of CV death.
White House spokesman Josh Earnest chided Republicans for failing to push forward with the president’s request for funding to combat the Zika virus and address an urgent public health crisis.